eighty-eight ( 63 per cent ) were malignant and included twenty-eight adenocarcinomas ( 31.8 per cent ) , twenty-four lymphosarcomas ( 27.3 per cent ) , nineteen carcinoids ( 21.6 per cent ) , and ten leiomyosarcomas ( 11.4 per cent ) .
C0001418
adenocarcinomas
C0007095
carcinoids